Table 2 ZNF529-AS1 expression associated with clinicopathologic characteristics (logistic regression)
Characteristics | Total (N) | Odds rati o(OR) | p value |
|---|---|---|---|
T stage (T2 and T3 and T4 vs. T1) | 371 | 2.375 (1.570–3.615) | < 0.001 |
N stage (N1 vs. N0) | 258 | 3.145 (0.397–64.047) | 0.324 |
M stage (M1 vs. M0) | 272 | 0.942 (0.112–7.944) | 0.953 |
Pathologic stage (Stage III and Stage IV vs. Stage I and Stage II) | 350 | 1.595 (0.985–2.606) | 0.059 |
Gender (Male vs. female) | 374 | 0.627 (0.403–0.969) | 0.036 |
Race (White vs. Asian and Black or African American) | 362 | 0.977 (0.647–1.476) | 0.913 |
Age (> 60 vs. ≤ 60) | 373 | 0.657 (0.436–0.987) | 0.044 |
Weight (> 70 vs. ≤ 70) | 346 | 0.685 (0.447–1.046) | 0.080 |
Height (≥ 170 vs. < 170) | 341 | 0.849 (0.550–1.307) | 0.456 |
BMI (> 25 vs. ≤ 25) | 337 | 0.795 (0.517–1.220) | 0.294 |
Residual tumor (R1 and R2 vs. R0) | 345 | 1.006 (0.384–2.639) | 0.990 |
Histologic grade (G3 and G4 vs. G1 and G2) | 369 | 2.800 (1.812–4.371) | < 0.001 |
AFP (ng/ml) (> 400 vs.≤ 400) | 280 | 4.235 (2.325–8.033) | < 0.001 |
Prothrombin time (> 4 vs. ≤ 4) | 297 | 1.248 (0.759–2.056) | 0.382 |
Albumin (g/dl) (≥ 3.5 vs. < 3.5) | 300 | 1.015 (0.592–1.747) | 0.956 |
Child–Pugh grade (B vs. A) | 240 | 5.445 (1.941–19.396) | 0.003 |
Vascular invasion (Yes vs. No) | 318 | 2.250 (1.406–3.636) | < 0.001 |